期刊
BRITISH JOURNAL OF DERMATOLOGY
卷 153, 期 3, 页码 486-497出版社
WILEY
DOI: 10.1111/j.1365-2133.2005.06893.x
关键词
biologics; efalizumab; etanercept; guideline; infliximab; psoriasis